PRAC2 and breast cancer: To further explore the role of HOXB-AS5 in BC progression, we detected the expression levels of HOXB-AS5 in the serum of pre-operation or post-operation BC patients, and the results showed that surgical treatment could decrease HOXB-AS5 expression in the serum of BC patients (P = 0.0027, Figure 3F).